MDXG NASDAQ
MiMedx Group, Inc.
1W: -7.8%
1M: -16.7%
3M: -7.8%
YTD: -39.8%
1Y: -42.3%
3Y: -35.9%
5Y: -44.3%
$3.90
+0.05 (+1.30%)
After Hours: $3.87 (-0.03, -0.77%)
Weekly Expected Move ±7.5%
$3
$4
$4
$4
$4
Credit Risk of going bust: lower than 90% of companies Debt: 0.3% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down more than 99.9%), MiMedx Group, Inc. would be worth roughly what it owes.
Total debt $1.5M against a stock market value of $561.2M.
Distance to default 13.94 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $1.5M (short-term plus half of long-term), stock volatility 42.3%; Altman Z'' 6.88. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.00 (down more than 99.9%), MiMedx Group, Inc. would be worth roughly what it owes.
Total debt $1.5M against a stock market value of $561.2M.
Distance to default 13.94 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $1.5M (short-term plus half of long-term), stock volatility 42.3%; Altman Z'' 6.88. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
3 relationships3
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2022-12-08
Earliest Filing
2024-12-16
Latest Filing
partner: 2
supplier: 1
Counterparties (Filed by MDXG)
3 relationshipsCompanies named in MDXG's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| CPVF II West Oak LLC | — | supplier | Landlord providing lease amendment for corporate headquarters premises | 2024-12-16 | View |
| Global Health Solutions, Inc. | — | partner | Partner providing proprietary antimicrobial technology platform and particulate collagen matrix product under a license | 2022-12-08 | View |
| Turn Therapeutics | TTRX | partner | Trade name of Global Health Solutions, Inc., providing proprietary antimicrobial technology platform and particulate col | 2022-12-08 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-16 | Other Events | View | |
| 2026-08-11 | Material Agreement; Regulation FD; Exhibits | Agreement | View |
| 2026-07-29 | Material Agreement; Regulation FD; Exhibits | Agreement | View |
| 2026-07-29 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-06-16 | Bylaws Amendment; Shareholder Vote | View | |
| 2026-04-29 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-04-16 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-02-25 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2026-01-12 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-10-29 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-09-03 | Regulation FD Disclosure | View | |
| 2025-07-30 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-06-20 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-13 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-04-30 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-02-27 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-02-26 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-01-14 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2024-12-16 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2024-11-18 | Regulation FD Disclosure; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR